The efficacy of polymyxin B in treating stroke-associated pneumonia with carbapenem-resistant Gram-negative bacteria infections: a multicenter real-world study using propensity score matching

The efficacy of polymyxin B in treating stroke-associated pneumonia with carbapenem-resistant Gram-negative bacteria infections: a multicenter real-world study using propensity score matching

ObjectivesInfection with Carbapenem-resistant Gram-negative bacteria (CR-GNB) poses further challenges in treating stroke-associated pneumonia (SAP) patients. This multicenter retrospective study aimed to evaluate the efficacy of polymyxin B (PMB) in CR-GNB-infected SAP patients and to identify fact...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hai-Hui Zhuang, Qi-Hua Chen, Wei Wang, Qiang Qu, Wei-Xin Xu, Qin Hu, Xiao-Li Wu, Ying Chen, Qing Wan, Tian-Tian Xu, Wen-Ming Long, Yue Luo, Hai-Nan Zhang, Jian Qu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Series:	Frontiers in Pharmacology
Subjects:	stroke-associated pneumonia polymyxin B carbapenem-resistant gram-negative bacteria clinical efficacy microbial efficacy
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1413563/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The efficacy and safety of ceftazidime/avibactam or polymyxin B based regimens for carbapenem-resistant Pseudomonas aeruginosa infection: a multicenter real-world and propensity score-matched study
by: Wen-Ming Long, et al.
Published: (2025-03-01)

Risk Factors and Prognosis of Polymyxin- and Carbapenem-Resistant Enterobacteriaceae Infections: A Propensity-Matched Real-World Study
by: Jian Xu, et al.
Published: (2025-05-01)

Factors Associated with Successful Treatment of Carbapenem-Resistant Gram-Negative Bacilli Infections Using Intravenous Colistin Sulfate in China: A Real-World Retrospective Study
by: Gao W, et al.
Published: (2025-04-01)

Concerns about statistical analyses in the study on polymyxin B treatment of carbapenem-resistant gram-negative bacilli infections
by: Jing Zhao, et al.
Published: (2025-09-01)

Polymyxin Including Therapy Versus Colistin Including Therapy In The Therapy Of Carbapenem-Resistant Gram-Negative Infections: A Retrospective Matched Cohort Study
by: Merve Mert Vahabi, et al.
Published: (2024-12-01)

Real-world data on the effects of colistin sulfate and polymyxin B sulfate in the treatment of pneumonia induced by CR-GNB
by: Di Liu, et al.
Published: (2024-07-01)

Colistin sulfate versus polymyxin B for the treatment of infections caused by carbapenem-resistant Acinetobacter baumannii: a multicenter retrospective cohort study
by: Hongmei Liu, et al.
Published: (2025-05-01)

Predictive factors for 30-day mortality after polymyxin B treatment of carbapenem-resistant Gram-negative bacilli infections
by: Simin Zhou, et al.
Published: (2025-05-01)

Concerns about statistical analyses in the study on polymyxin B treatment of carbapenem-resistant gram-negative bacilli infections: authors’ reply
by: Simin Zhou, et al.
Published: (2025-09-01)

Efficacy and safety of polymyxin B sulfate versus colistin sulfate in ICU patients with nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii: a multicenter, propensity score-matched, real-world cohort study
by: Wei Bu, et al.
Published: (2025-03-01)

Efficacy of ceftazidime-avibactam with or without polymyxin for carbapenem-resistant Klebsiella pneumoniae infections after initial treatment with polymyxin
by: Jingli Lu, et al.
Published: (2025-01-01)

Discovery of a novel polymyxin adjuvant against multidrug-resistant gram-negative bacteria through oxidative stress modulation
by: Taotao Lu, et al.
Published: (2025-03-01)

Cross-Sectional Assessment on Carbapenem-Resistant Gram-Negative Bacteria Isolated from Patients in Moldova
by: Vadim Nirca, et al.
Published: (2025-02-01)

Efficacy, Safety, and Cost-Effectiveness Analysis of Ceftazidime-Avibactam versus Polymyxin B in the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections: A Target Trial Emulation
by: Na Hu, et al.
Published: (2025-05-01)

Monte Carlo simulation to optimize polymyxin B dosing regimens for the treatment of Gram-negative bacteremia
by: Yingying Yu, et al.
Published: (2025-02-01)

Poor Glycemic Control in Carbapenem-Resistant Klebsiella pneumoniae Infections: Impact on Epidemiological Features, Mortality Risks, and Polymyxin Resistance
by: Wang Q, et al.
Published: (2025-02-01)

Carbapenem-Resistant Gram-Negative Bacterial Infections at a Tertiary Health Care Center in Nepal: An Observational Study
by: Dimpi Konwar, et al.
Published: (2024-12-01)

New Insights on the Carbapenem-resistant Gram Negative-associated-Infections: Challenges and Opportunities
by: Samar S. Mabrouk, et al.
Published: (2023-06-01)

External validation of the ICU-CARB score to predict carbapenem-resistant gram-negative bacteria carriage in critically ill patients upon ICU admission: a multicenter analysis
by: Tong Wu, et al.
Published: (2024-12-01)

Ceftazidime–Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region
by: Rıdvan Dumlu, et al.
Published: (2024-10-01)

Disruption of mgrB gene by ISkpn14 sourced from a bla KPC−2 carrying plasmid mediating polymyxin resistance against carbapenem-resistant Klebsiella pneumoniae during treatment: study on the underlying mechanisms
by: Ziyao Li, et al.
Published: (2024-10-01)

Clinical Eﬃcacy of Ceftazidime-Avibactam in the Treatment of Infections Caused by Carbapenem–Resistant Gram-Negative Bacteria
by: S. V. Yakovlev
Published: (2021-10-01)

Epidemiological Trends and Drug Resistance Patterns of Carbapenem-Resistant Gram-Negative Bacteria: A Retrospective Study in a Tertiary Hospital in China (2019-2024)
by: Hou B, et al.
Published: (2025-06-01)

Impact of overlapping fungal infection on the occurrence and prognosis of carbapenem-resistant gram-negative bacilli infection
by: Jiahuan Li, et al.
Published: (2025-05-01)

Carbapenem resistance in gram-negative pathogens in an Iranian hospital: high prevalence of OXA-type carbapenemase genes
by: Setareh Mamishi, et al.
Published: (2025-01-01)

Gold Nanoparticles Functionalized With 5-Amino-2-Mercaptobenzimidazole: A Promising Antimicrobial Strategy Against Carbapenem-Resistant Gram-Negative Bacteria
by: Zhang J, et al.
Published: (2025-02-01)

Case Report: Polymyxin E-associated reversible leukopenia
by: Suxin Wan, et al.
Published: (2025-08-01)

A Tentative Clinical Study: Colistin Combined with Ceftazidime/Avibactam in the Treatment of Carbapenem-Resistant Gram-Negative Bacilli Infection
by: Zhang R, et al.
Published: (2025-08-01)

Efficacy and safety of cefiderocol in the treatment of infections caused by Gram-negative bacteria: a systematic review and meta-analysis
by: Xiaocui Huang, et al.
Published: (2024-12-01)

Regional insights on the prevalence and antimicrobial susceptibility pattern of carbapenem and colistin-resistant gram-negative bacteria: an observational cross-sectional study from Karachi, Pakistan
by: Nazia Khursheed, et al.
Published: (2025-02-01)

Pharmacokinetics of colistin in patients with multi-drug resistant Gram-negative bacterial infections
by: Harivenkatesh Natarajan, et al.
Published: (2024-12-01)

Prevalence of multidrug resistant gram-negative bacteria and associated factors among gram-negative blood culture isolates at Tikur Anbessa Specialized Hospital: a retrospective study
by: Eskedar Ferdu Azerefegne, et al.
Published: (2025-08-01)

Economic evaluation of ceftazidime-avibactam vs. polymyxin B for treatment of hospital-acquired and ventilator-associated bacterial pneumonia
by: Jessica Matuoka, et al.
Published: (2025-07-01)

Comparative evaluation of susceptibility testing methods for colistin and polymyxin B among clinical isolates of carbapenem- resistant Klebsiella pneumoniae and Acinetobacter baumannii
by: Yamuna Devi Bakthavatchalam, et al.
Published: (2018-06-01)

Surveillance of Multidrug-Resistant Genes in Clinically Significant Gram-Negative Bacteria Isolated from Hospital Wastewater
by: Shriya C. Shetty, et al.
Published: (2025-06-01)

Evaluation of the NG-Test Carba 5 for the clinical detection of carbapenemase-producing gram-negative bacteria
by: Hai-Feng Qin, et al.
Published: (2025-03-01)

Understanding the burden of antibiotic resistance: a decade of carbapenem-resistant Gram-negative bacterial infections in Italian intensive care units
by: Giovanni Scaglione, et al.
Published: (2024-06-01)

Nanoformulation of Polymyxin E Through Complex Coacervation: A Pharmacokinetic Analysis
by: Xiaobao Chen, et al.
Published: (2025-01-01)

Efficacy, safety, and therapeutic drug monitoring of polymyxin B sulfate and colistin sulfate in critically ill patients: a real-world retrospective study
by: Yijing Zhang, et al.
Published: (2025-01-01)

Corrigendum: Understanding the burden of antibiotic resistance: a decade of carbapenem-resistant Gram-negative bacterial infections in Italian intensive care units
by: Giovanni Scaglione, et al.
Published: (2025-03-01)